PCH
CSTL icon

Polar Capital Holdings’s Castle Biosciences CSTL Stock Holding History

Polar Capital Holdings’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,398
Closed -$184K – 286
2023
Q2 		$184K Hold
13,398
– – ﹤0.01% 285
2023
Q1 		$304K Hold
13,398
– – ﹤0.01% 291
2022
Q4 		$315K Sell
13,398
-35,587
-73% -$825K ﹤0.01% 302
2022
Q3 		$1.28K Hold
48,985
– – 0.01% 289
2022
Q2 		$1.07K Buy
48,985
+4,000
+9% +$92.9K 0.01% 299
2022
Q1 		$2.02K Hold
44,985
– – 0.01% 304
2021
Q4 		$1.93K Buy
44,985
+8,107
+22% +$424K 0.01% 298
2021
Q3 		$2.45K Buy
36,878
+8,117
+28% +$571K 0.01% 301
2021
Q2 		$2.11K Buy
+28,761
New +$1.9M 0.01% 304

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Polar Capital Holdings's CSTL Position: Q3 2023 in Review

Polar Capital Holdings sold out of Castle Biosciences (CSTL) in Q3 2023, closing a stake of 13,398 shares — an estimated $184K sold.

Polar Capital Holdings first reported a position in CSTL in Q2 2021 and held it in 9 quarters. The position peaked at $315K in Q4 2022. 135 funds tracked by Wall St. Rank hold CSTL as of Q3 2023.

  • Polar Capital Holdings reported no remaining Castle Biosciences position as of Q3 2023 after selling out during the quarter.
  • Polar Capital Holdings sold 13,398 Castle Biosciences shares in Q3 2023, an estimated $184K.
  • Polar Capital Holdings first reported a position in Castle Biosciences in Q2 2021 and held it in 9 quarters.
  • Polar Capital Holdings's Castle Biosciences position peaked at $315K in Q4 2022.
  • 135 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2023.

Based on Polar Capital Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.